Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics

被引：4
|
作者：
Sarah, Allegra [1 ,2 ]
Dondi, Emma [1 ]
De Francia, Silvia [1 ]
机构：
[1] Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Orbassano, TO, Italy
[2] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Clin Pharmacol Serv Franco Ghezzo, Reg Gonzole 10, I-10043 Turin, TO, Italy
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2023年 / 19卷 / 11期
关键词：
Chemotherapy; Cancer; Precision Medicine; Personalized Treatment; IMATINIB;
D O I：
10.1080/17425255.2023.2277758
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：733 / 739
页数：7
相关论文
共 50 条
  • [41] Tyrosine kinase inhibitors: a clinical perspective.
    Goel S.
    Mani S.
    Perez-Soler R.
    Current Oncology Reports, 2002, 4 (1) : 9 - 19
  • [42] EGFR mutations and EGFR tyrosine kinase inhibitors
    Torri, Valter
    Broggini, Massimo
    Garassino, Marina Chiara
    LANCET ONCOLOGY, 2015, 16 (07) : 746 - 748
  • [43] Tyrosine kinase inhibitors in the treatment of systemic mastocytosis
    Ustun, Celalettin
    DeRemer, David L.
    Akin, Cem
    LEUKEMIA RESEARCH, 2011, 35 (09) : 1143 - 1152
  • [44] Adverse Effects of Combined Tyrosine Kinase Inhibitors
    Lu, Shun
    Li, Ziming
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (11) : E182 - E183
  • [45] Future treatment of Diabetes - Tyrosine Kinase inhibitors
    Kumar, S. Aakash
    Patel, Snehal S.
    Patel, Shreya
    Parikh, Palak
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) : 61 - 71
  • [46] Protein tyrosine kinase inhibitors as anticancer agents
    Supuran, CT
    Scozzafava, A
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (01) : 35 - 53
  • [47] Fasting plus tyrosine kinase inhibitors in cancer
    Caffa, Irene
    Longo, Valter D.
    Nencioni, Alessio
    AGING-US, 2015, 7 (12): : 1026 - 1027
  • [48] Integrating Clinical Pharmacology Concepts in Individualized Therapy With Tyrosine Kinase Inhibitors
    Drenberg, C. D.
    Baker, S. D.
    Sparreboom, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (03) : 215 - 219
  • [49] Tyrosine kinase inhibitors: muco-cutaneous side effects at the microscope
    Grasso, V.
    Vassallo, C.
    Croci, G.
    Brazzelli, V.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2014, 149 (03): : 317 - 327
  • [50] Small molecule tyrosine kinase inhibitors in glioblastoma
    Kim, Gayoung
    Ko, Young Tag
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (04) : 385 - 394
12345